CR Zizhu

2020-05-10 21:02
Reading quantity:846

On 27th Jun 2016, sales Partnership with CR Zizhu can potentially access 5 times the number of hospitals in a short period of time. China Resources Zizhu is granted the sole distribution and promotion rights of GeneSoft® and will include the drug within its existing hospital network in Mainland China. Relying on CR Zizhu with strong track records in ophthalmology, this partnership can help Uni-Bio maintain a foothold in the competitive PRC market amid aggressive price reduction pressure.

Scan and Focus
Scan and Focus